Impact Capital Partners’s Medpace MEDP Stock Holding History

Impact Capital Partners’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-405	Closed	-$227K	–	286
2025 Q4	$227K	Buy	405 +13	+3%	+$7.38K	0.07%	255
2025 Q3	$202K	Buy	+392	New	+$171K	0.06%	265

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Impact Capital Partners's MEDP Position: Q1 2026 in Review

Impact Capital Partners sold out of Medpace (MEDP) in Q1 2026, closing a stake of 405 shares — an estimated $227K sold.

Impact Capital Partners first reported a position in MEDP in Q3 2025 and held it in 2 quarters. The position peaked at $227K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Impact Capital Partners reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
Impact Capital Partners sold 405 Medpace shares in Q1 2026, an estimated $227K.
Impact Capital Partners first reported a position in Medpace in Q3 2025 and held it in 2 quarters.
Impact Capital Partners's Medpace position peaked at $227K in Q4 2025.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Impact Capital Partners's 13F filing for Q1 2026, filed 10 Apr 2026.